These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 22990541)
1. Cytotoxic antibodies monitoring in kidney transplantation--their clinical relevance and challenges. Gîngu C; Moise A; Constantinescu I; Serbănescu B; Surcel C; Sinescu I Rom J Morphol Embryol; 2012; 53(3):515-9. PubMed ID: 22990541 [TBL] [Abstract][Full Text] [Related]
2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
4. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503 [TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767 [TBL] [Abstract][Full Text] [Related]
6. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation. Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326 [TBL] [Abstract][Full Text] [Related]
7. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development. Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI Clin Transpl; 2006; ():241-53. PubMed ID: 18365382 [TBL] [Abstract][Full Text] [Related]
8. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience. Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M Clin Transpl; 2011; ():373-9. PubMed ID: 22755434 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules. Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902 [TBL] [Abstract][Full Text] [Related]
11. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation. Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991 [TBL] [Abstract][Full Text] [Related]
12. Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience. Mujtaba MA; Fridell JA; Higgins N; Sharfuddin AA; Yaqub MS; Kandula P; Chen J; Mishler DP; Lobashevsky A; Book B; Powelson J; Taber TE Clin Transplant; 2012; 26(5):E492-9. PubMed ID: 22938159 [TBL] [Abstract][Full Text] [Related]
13. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome. Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725 [TBL] [Abstract][Full Text] [Related]
14. Long-term post transplant alloantibody monitoring: a single center experience. Ntokou IS; Boletis JN; Apostolaki M; Vrani V; Zavos G; Kostakis A; Iniotaki A Clin Transpl; 2011; ():341-50. PubMed ID: 22755429 [TBL] [Abstract][Full Text] [Related]
15. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592 [TBL] [Abstract][Full Text] [Related]
17. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes. Banasik M; Boratyńska M; Kościelska-Kasprzak K; Krajewska M; Mazanowska O; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Dawiskiba T; Chudoba P; Klinger M Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747 [TBL] [Abstract][Full Text] [Related]